Redwood Grove Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5M Buy
1,525,300
+233,500
+18% +$5.4M 9.51% 1
2026
Q1
$30.9M Sell
1,291,800
-265,200
-17% -$6.48M 9.98% 1
2025
Q4
$35.2M Buy
1,557,000
+150,000
+11% +$3.26M 10.05% 1
2025
Q3
$28.3M Buy
1,407,000
+97,000
+7% +$1.62M 8.11% 2
2025
Q2
$18.7M Buy
1,310,000
+450,000
+52% +$5.26M 6.21% 2
2025
Q1
$9.03M Buy
+860,000
New +$9.73M 3.24% 19

Other funds holding ELAN

Redwood Grove Capital's ELAN Position: Q2 2026 in Review

Redwood Grove Capital increased its Elanco Animal Health (ELAN) stake by 18% in Q2 2026, buying an estimated $5.4M and bringing the position to 1,525,300 shares worth $37.5M. The position accounts for 9.51% of the portfolio, ranked #1.

Redwood Grove Capital first reported a position in ELAN in Q1 2025 and has held it in 6 quarters since. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Redwood Grove Capital held 1,525,300 shares of Elanco Animal Health worth $37.5M as of Q2 2026.
  • Redwood Grove Capital bought 233,500 Elanco Animal Health shares in Q2 2026, an estimated $5.4M.
  • Elanco Animal Health made up 9.51% of Redwood Grove Capital's portfolio in Q2 2026, its #1 holding.
  • Redwood Grove Capital first reported a position in Elanco Animal Health in Q1 2025 and has held it in 6 quarters since.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Redwood Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.